Facebook
Twitter
LinkedIn
Forward
Biosimilars in Vision: Addressing Drug Trends and Managed Care Strategies
Pricing: Free for Members, $30 for Non-Members
Course Description
As treatment options continue to expand for highly prevalent eye disorders such as age-related macular degeneration (AMD) and diabetic macular edema (DME), it is essential to stay up to date with novel agents and biosimilars in the ophthalmic category. This session will include an overview of the anti-VEGF drugs used for ophthalmic conditions, focusing on their utilization trends and management strategies. Additionally, the faculty will discuss the management of interchangeable biosimilars from a medical benefit perspective. Join this session to learn about current drug trends, clinical strategies, and the robust pipeline in the biosimilars ophthalmic space.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Explain current medical drug trends in the ophthalmic space.
- Outline payer management strategies for anti-VEGF drugs.
- Discuss challenges that health plans face with interchangeable biosimilars and propose solutions.
- Identify ophthalmic drugs in the pipeline and their cost impacts.
Faculty
Prerakkumar Parikh, PharmD
Director, Specialty Clinical Solutions
Magellan Rx Management
San Jose, CA
Sneha Sharma, PharmD
Director, Specialty Clinical Solutions
Magellan Rx Management
Albuquerque, NM
Moderator
Jeremy Garris, BS Pharmacy
VP Clinical Solutions
Exponent Health
Louisville, Kentucky
Financial Relationship Disclosures
| Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
| Prerakkumar Parikh Faculty | Employee: Magellan Rx Management |
| Sneha Sharma Faculty | Employee: Magellan Rx Management |
Tracy McDowd | Disclosed no relevant financial relationships. |
| Mason Johnson Planner | Disclosed no relevant financial relationships. |
- AMCP Staff have disclosed no relevant financial relationships.
- If applicable, relevant financial relationships have been mitigated and documented.
- Content has undergone a peer review to ensure content validity.
Accreditation:
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN:0233-0000-23-017-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: March 23, 2023 • Expiration Date: December 31, 2024
Activity Fee: Free for Members and $30 for Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2023. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. - 1.25 Certificate of Completion
Price
Required Hardware/software
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities